Dr. Frederick M Schnell , MD
Specialist • Macon, GA
800 1st St, Suite 410
Macon, GA 312018300
This profile restates public CMS/NPPES data; T-MedInfo gives no medical advice — consult a licensed professional, and call 911 for emergencies.
-
NPI assigned on June 26, 2006; this date does not establish years in practice.
-
Published CMS data list 25,485 Original Medicare Part B services in 2017.
Source: CMS, Medicare Physician & Other Practitioners – by Provider and Service, 2017. Published rows only; this is not a quality measure.
-
Published Part B service records, 2017:
- J9267 — Injection, paclitaxel, 1 mg: 5,935 service units.
- J1453 — Injection, fosaprepitant, 1 mg: 3,750 service units.
- J0885 — Injection, epoetin alfa, (for non-esrd use), 1000 units: 3,110 service units.
Source: CMS, Medicare Physician & Other Practitioners – by Provider and Service, 2017. Units differ by code; these are not visits or a measure of quality.
See all 49 records in the table · Guide: How to read Medicare Part B data
-
Published CMS data list 30 Medicare Part D prescriptions, including refills, in 2023.
Source: CMS, Medicare Part D Prescribers – by Provider and Drug, 2023. Published rows only; this is not a quality measure.
-
Published Part D records, 2023:
- Oxycodone Hcl — 16 prescription fills, including refills.
- Fentanyl — 14 prescription fills, including refills.
Source: CMS, Medicare Part D Prescribers – by Provider and Drug, 2023. Drug names come from pharmacy claims. Listing a drug here is not an endorsement or a recommendation.
See the full table · Guide: How to read Medicare Part D prescriber data
-
Medicare Part D prescriptions went from 1,061 in 2016 to 30 in 2023.
Source: CMS, Medicare Part D Prescribers – by Provider and Drug, 2016–2023.
Practice Location & Contact Primary Location
800 1st St
Suite 410
Macon, GA 312018300
Matched by practice address or phone in NPPES. A shared address or phone does not confirm that this clinician works there.
What Public CMS Data Show
Specialist: NPPES taxonomy is a reported classification, not proof of board certification.
Medicare-allowed amount
About $455,651 in 2017
The total amount Medicare approved for these services in 2017. It includes what Medicare paid and what patients or their other insurance owed, such as the deductible and coinsurance.
It shows the total cost of this clinician's Original Medicare services under Medicare's fee rules.
What this does not show: Medicare-allowed amount
This is not the clinician's income. Part of it can go to a clinic or group practice, staff, equipment or drugs. It is not the price you will pay.
Source: CMS, Medicare Physician & Other Practitioners – by Provider and Service, 2017.
Paid by Medicare
About $374,784 in 2017
The part of the Medicare-allowed amount that Medicare itself paid in 2017, after patients' deductibles and coinsurance.
The gap between the allowed amount and this number is roughly what patients and their other insurance paid.
What this does not show: Paid by Medicare
This is not the clinician's income and not a measure of quality.
Source: CMS, Medicare Physician & Other Practitioners – by Provider and Service, 2017.
30-day fills
30 standardized 30-day fills in 2023
CMS converts prescriptions to 30-day supplies so they can be compared. A 90-day prescription counts as about three 30-day fills.
What this does not show: 30-day fills
It is not a count of patients and not a measure of quality.
Part D drug cost
$1,787 in 2023
The total cost of these prescriptions in 2023, paid by Medicare drug plans, patients and other payers together.
It shows the total spending on drugs this clinician prescribed, not what any one patient paid.
What this does not show: Part D drug cost
A higher cost often reflects the type of medicines a specialty uses. It is not your out-of-pocket cost and not a measure of quality.
Source: CMS, Medicare Part D Prescribers – by Provider and Drug, 2023.
Open Payments general payments, program year 2025
All general payments: $1,958.20 across 5 records.
By nature of payment
- Consulting Fee: $1,785.00 across 2 records.
- Food and Beverage: $173.20 across 3 records.
Reporting-company totals (3 largest of 4)
- Regeneron Pharmaceuticals, Inc.: $1,785.00 across 2 records.
- Takeda Pharmaceuticals U.S.A., Inc.: $121.10 across 1 record.
- Daiichi Sankyo Inc.: $29.43 across 1 record.
A reported payment does not necessarily mean the financial relationship is improper and is not a measure of care quality. Clinicians can review and dispute these records.
Source: Calculated by T-MedInfo from CMS Open Payments general-payment records for program year 2025 (published June 30, 2026).
NPI first issued
2006
The year this clinician's National Provider Identifier (NPI) was issued. An NPI is a unique 10-digit ID that US health care providers use for billing.
What this does not show: NPI first issued
NPIs have been issued only since 2005, so this year is not necessarily when the clinician started practicing.
Source: CMS NPPES NPI Registry.
Medicare assignment not listed
CMS data do not show whether this clinician accepts Medicare assignment. This does not mean they do not accept Medicare. Ask the office.
Medicare assignment applies to Original Medicare. It does not tell you whether the clinician is in a Medicare Advantage plan's network, accepts other insurance, or is taking new patients.
Source: CMS Doctors and Clinicians; Medicare.gov, “Does your provider accept Medicare as full payment?”
No telehealth indicator
CMS shows this indicator only when recent Medicare claims include telehealth services. The clinician may still offer telehealth; ask the office.
Source: CMS, Telehealth Indicator on Medicare Care Compare (fact sheet, January 2023); CMS Doctors and Clinicians.
Compared with the same specialty in Macon and Georgia
Billing and prescribing volume is not a quality rating.
Medicare Part B
Comparisons use 2024 data. The latest CMS data for Dr. Schnell are from 2017.
Medicare Part D
Comparisons use 2024 data. The latest CMS data for Dr. Schnell are from 2023.
30 active clinicians are listed under Specialist with a practice address in Macon, GA (852 in Georgia).
Addresses are self-reported to NPPES and may be out of date.
Telehealth indicator in Macon
10% of these 30 clinicians have the CMS telehealth indicator.
36.7% of these 30 clinicians are listed by CMS as accepting Medicare assignment.
CMS data by year
Changes may reflect reporting, coverage or privacy limits, not changes in care quality.
-
Medicare Part B services
CMS data for Medicare Part B services are available for 2017 only.
-
Medicare-allowed amount
CMS data for Medicare-allowed amount are available for 2017 only.
-
Paid by Medicare
CMS data for Medicare payment amount are available for 2017 only.
-
Medicare Part D prescriptions
Medicare Part D prescriptions decreased 97% from 1,061 in 2016 to 30 in 2023.
- 2016: 1,061
- 2017: 847
- 2018: 171
- 2021: 12
- 2023: 30
-
30-day fills
30-day fills decreased 98% from 1,310 in 2016 to 30 in 2023.
- 2016: 1,310
- 2017: 1,034
- 2018: 279
- 2021: 12
- 2023: 30
-
Part D drug cost
Part D drug cost decreased 100% from $1,626,898 in 2016 to $1,787 in 2023.
- 2016: $1,626,898
- 2017: $1,277,103
- 2018: $8,966
- 2021: $439
- 2023: $1,787
-
Industry payments (Open Payments)
Industry payments (Open Payments) decreased 82% from $10,610.62 in 2021 to $1,958.20 in 2025.
- 2021: $10,610.62
- 2022: $13,900.35
- 2023: $10,840.14
- 2024: $3,078.27
- 2025: $1,958.20
Sources: CMS Medicare Physician & Other Practitioners (2017), CMS Medicare Part D Prescribers (2023), CMS Open Payments (2025), CMS Doctors and Clinicians, CMS NPPES NPI Registry. Specialty names follow the NUCC Health Care Provider Taxonomy.
Text: T-MedInfo · Report an error.
Pharma & Medical Device Financial Disclosures
Payments and other transfers of value that drug and medical device companies reported to CMS Open Payments
Program year 2025 (payments made January 1 – December 31, 2025): fewer than 11 records totaling $1,958.20.
| Manufacturer | Payment Nature | Product | Type | Amount ($) |
|---|---|---|---|---|
| Regeneron Pharmaceuticals, Inc. |
Consulting Fee
Cash or cash equivalent
|
LYNOZYFIC | General | $1,190.00 |
| Regeneron Pharmaceuticals, Inc. |
Consulting Fee
Cash or cash equivalent
|
LYNOZYFIC | General | $595.00 |
| Takeda Pharmaceuticals U.S.A., Inc. |
Food and Beverage
In-kind items and services
|
— | General | $121.10 |
| Daiichi Sankyo Inc. |
Food and Beverage
In-kind items and services
|
DATROWAY | General | $29.43 |
| Gilead Sciences, Inc. |
Food and Beverage
In-kind items and services
|
Trodelvy | General | $22.67 |
Source: CMS Open Payments, program year 2025, released June 30, 2026.
Performed Procedures & Service Volume
CPT® is a registered trademark of the American Medical Association. CPT codes, descriptions and other data only are copyright 2016 American Medical Association. All rights reserved. Applicable FARS/HHSARS apply. Descriptions of CPT codes are the AMA's CPT Consumer Friendly Descriptors as published by CMS in the Medicare Physician & Other Practitioners – by Provider and Service data, 2017; they are plain-language summaries, not for clinical coding or documentation. HCPCS Level II codes and descriptions are from CMS. Fee schedules, relative value units, conversion factors and/or related components are not assigned by the AMA, are not part of CPT, and the AMA is not recommending their use. The AMA does not directly or indirectly practice medicine or dispense medical services. The AMA assumes no liability for data contained or not contained herein.
| HCPCS Code | Services | Patients | Submitted Charge | Medicare Allowed |
|---|---|---|---|---|
|
J9267
Injection, paclitaxel, 1 mg
|
5,935 | 14 | $1.00 | $0.15 |
|
J1453
Injection, fosaprepitant, 1 mg
|
3,750 | 13 | $4.00 | $1.90 |
|
J0885
Injection, epoetin alfa, (for non-esrd use), 1000 units
|
3,110 | 24 | $30.00 | $13.07 |
|
Q9967
Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml
|
3,040 | 39 | $1.00 | $0.12 |
|
J0897
Injection, denosumab, 1 mg
|
2,100 | 23 | $39.00 | $16.64 |
|
J1100
Injection, dexamethasone sodium phosphate, 1 mg
|
1,072 | 41 | $3.00 | $0.11 |
|
85025
Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count
|
772 | 296 | $42.00 | $10.42 |
|
99214
Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more
|
710 | 246 | $267.00 | $101.36 |
|
J2469
Injection, palonosetron hcl, 25 mcg
|
610 | 33 | $81.00 | $21.75 |
|
80053
Blood test, comprehensive group of blood chemicals
|
461 | 221 | $61.00 | $10.74 |
|
99213
Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more
|
450 | 325 | $180.00 | $69.01 |
|
G9678
Oncology care model (ocm) monthly enhanced oncology services (meos) payment for ocm enhanced services. g9678 payments may only be made to ocm practitioners for ocm beneficiaries for the furnishment of enhanced services as defined in the ocm participation a
|
435 | 80 | $160.00 | $156.80 |
|
83615
Lactate dehydrogenase (enzyme) level
|
383 | 206 | $23.00 | $3.75 |
|
83735
Magnesium level
|
244 | 114 | $60.00 | $8.98 |
|
96367
Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less
|
241 | 48 | $85.00 | $28.36 |
|
J3480
Injection, potassium chloride, per 2 meq
|
220 | 11 | $2.00 | $0.13 |
|
96413
Administration of chemotherapy into vein, 1 hour or less
|
190 | 62 | $362.08 | $123.56 |
|
J9045
Injection, carboplatin, 50 mg
|
179 | 14 | $248.00 | $3.46 |
|
36415
Insertion of needle into vein for collection of blood sample
|
157 | 101 | $12.00 | $2.93 |
|
96372
Injection of drug or substance under skin or into muscle
|
151 | 61 | $57.00 | $23.50 |
|
84550
Uric acid level, blood
|
123 | 69 | $18.00 | $2.70 |
|
J3489
Injection, zoledronic acid, 1 mg
|
106 | 15 | $128.00 | $13.15 |
|
J3475
Injection, magnesium sulfate, per 500 mg
|
94 | 13 | $2.00 | $0.48 |
|
96375
Injection of additional new drug or substance into vein
|
81 | 37 | $58.00 | $20.39 |
|
96523
Irrigation of implanted venous access drug delivery device
|
72 | 38 | $59.00 | $22.19 |
(top 25 shown)
Source: CMS Part B by Provider and Service, 2017; services under 11 beneficiaries omitted by CMS. Privacy limits
Submitted charges are billed amounts, not a price quote for your visit.
Medicare Part D Prescribing Profile & Medications
Medicare Part D prescriptions filled, including refills, in 2023.
| Brand Name | Generic Name | Prescriptions | Day Supply | Total Cost | Patients |
|---|---|---|---|---|---|
| Oxycodone Hcl | Oxycodone Hcl | 16 | 233 | $309.91 | — |
| Fentanyl | Fentanyl | 14 | 406 | $1,477.20 | — |
Source: CMS Part D by Provider and Drug, 2023; rows below 11 claims omitted by CMS; volume isn’t quality. Privacy limits
Specialties & License Numbers Reported to NPPES
NUCC Taxonomy Code: 174400000X
An individual educated and trained in an applied knowledge discipline used in the performance of work at a level requiring knowledge and skills beyond or apart from that provided by a general education or liberal arts degree.
Additional State Medicaid & Healthcare Payer Identifiers
Clinicians Sharing This Practice Address or Phone
Clinicians sharing this NPPES address, phone or fax; a shared contact does not mean they work together.
Internal Medicine - Hematology & Oncology
Specialist
Doctor of Medicine (M.D.)
Nurse Practitioner
Family Nurse Practitioner (Certified)
Physician Assistant - Medical
Physician Assistant (Certified)
Nurse Practitioner - Family
Nurse Practitioner (Certified)
Nurse Practitioner - Family
Family Nurse Practitioner (Certified)
Career & Practice History
NPI enumerated June 26, 2006.
No changes to the name, practice address, taxonomy or NPI status in this record have been observed in the monthly NPPES data files from January 2017 to August 2026.
NPI Administrative Meta
Other Specialists in Macon
- Dr. Linda Hendricks, MD
- Dr. Norman Donati, MD
- Dr. Muhammad Akbar, MD
- Dr. Ahmad Al-Hajj, MD
- Dr. Obinnaya Emerole, MD
- Dr. Saghir Ahmed, MD
Mailing Address
800 1st St, Suite 410
Macon, GA 312018300
Phone: 4787437068